Roy L. Hawke

Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity

Stephanie Faucette, Roy L. Hawke, Edward L. LeCluyse et al. · Drug Metabolism and Disposition · 2000 · 355 citations

Pharmacokinetics and Metabolic Profile of Free, Conjugated, and Total Silymarin Flavonolignans in Human Plasma after Oral Administration of Milk Thistle Extract

Zhiming Wen, Todd Dumas, Sarah J. Schrieber et al. · Drug Metabolism and Disposition · 2007 · 166 citations

Common Herbal Dietary Supplement-Drug Interactions.

Gary Asher, Amanda Corbett, Roy L. Hawke · PubMed · 2017 · 156 citations

Drug Safety, Drug Interactions, Molecular Pharmacology +11

Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C

Roy L. Hawke, Sarah J. Schrieber, Tedi A. Soule et al. · The Journal of Clinical Pharmacology · 2009 · 141 citations · Full text

KUPFFER CELL-MEDIATED IL-2 SUPPRESSION OF CYP3A ACTIVITY IN HUMAN HEPATOCYTES

Jeffrey A. Sunman, Roy L. Hawke, Edward L. LeCluyse et al. · Drug Metabolism and Disposition · 2004 · 111 citations